TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9918450

Group type: EXPERIMENTAL
Intervention: Active Compression-Decompression (ACD) CPR
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patients admitted to hospital
Number of subjects: 60

Group type: COMPARATOR
Intervention: Patients declared dead at the scene
Number of subjects: 60
Study: 7845167

Group type: EXPERIMENTAL
Intervention: Omeprazole 3x40 mg + Amoxicillin 3x750 mg for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical triple therapy containing bismuth and two antibiotics
Number of subjects: 0
Study: 2904006

Group type: EXPERIMENTAL
Intervention: 100 micrograms misoprostol
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: 200 micrograms misoprostol
Number of subjects: 420

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 420
Study: 31210361

Group type: EXPERIMENTAL
Intervention: Growth mindset peer context
Number of subjects: 134

Group type: COMPARATOR
Intervention: Fixed mindset peer context
Number of subjects: 134
Study: 28508396

Group type: EXPERIMENTAL
Intervention: Partner child intentionally defected
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Partner child was ignorant about how to play
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Apparatus broke
Number of subjects: 144
Study: 28950837

Group type: EXPERIMENTAL
Intervention: Active commuting to/from school
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Active Physical Education lessons
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Active school recess
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Sleep health promotion
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Integrated program incorporating all 4 interventions
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 300
Study: 25708419

Group type: EXPERIMENTAL
Intervention: Probiotic preparation administered twice a day from ICU admission until 7 days or discharge from ICU.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no probiotics administered).
Number of subjects: 150
Study: 23076723

Group type: EXPERIMENTAL
Intervention: rTMS-COG
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 20644484

Group type: EXPERIMENTAL
Intervention: 0.8 g MnCl2 (n = 11)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1.6 g MnCl2 (n = 9)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both doses (0.8 g and 1.6 g MnCl2)
Number of subjects: 20
Study: 18300337

Group type: EXPERIMENTAL
Intervention: 10-month program of tailored mailed print materials
Number of subjects: 543

Group type: COMPARATOR
Intervention: 10-month program of publicly available materials on diet and exercise
Number of subjects: 543
Study: 16628671

Group type: EXPERIMENTAL
Intervention: peginterferon α-2a plus ribavirin
Number of subjects: 216
Study: 12905094

Group type: EXPERIMENTAL
Intervention: Laboratory treadmill running test
Number of subjects: 10

Group type: COMPARATOR
Intervention: Field roller skiing test
Number of subjects: 10
Study: 10843351

Group type: EXPERIMENTAL
Intervention: 12-week group exercise program (90 minutes, three times per week)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 9158845

Group type: EXPERIMENTAL
Intervention: Taste information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin-plus-availability information
Number of subjects: 0

Group type: COMPARATOR
Intervention: No information
Number of subjects: 0
Study: 7942443

Group type: EXPERIMENTAL
Intervention: Bedside coagulation device
Number of subjects: 120

Group type: COMPARATOR
Intervention: Central laboratory aPTT testing
Number of subjects: 120
Study: 3067116

Group type: EXPERIMENTAL
Intervention: Tianeptine (37.5 mg per day)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Amitriptyline (75 mg per day)
Number of subjects: 129
Study: 29691148

Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blocker (ARB) - valsartan
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ACE inhibitor (ACEI) - ramipril
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 28533054

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine (2+1 doses at 3½-5-11 months or 6-8-11 months)
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine (3+1 doses at ages 2½-3½-5-11 months)
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine (2 catch-up doses administered 2 months apart)
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: Adverse events monitoring
Number of subjects: 1158
Study: 26386693

Group type: EXPERIMENTAL
Intervention: Meal rich in saturated fat (butter) with 1.8 grams of LCn‐3PUFA
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Meal rich in omega-6 polyunsaturated fatty acids (sunflower seed oil) with 1.8 grams of LCn‐3PUFA
Number of subjects: 26

Group type: COMPARATOR
Intervention: Both saturated fat and omega-6 fat groups with 1.8 grams of LCn‐3PUFA
Number of subjects: 26
Study: 23846749

Group type: EXPERIMENTAL
Intervention: Hydromorphone titration protocol (0.5 mg intravenous hydromorphone initially, with a second dose of 0.5 mg if requested)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Usual care (any dose of any intravenous opioid)
Number of subjects: 319
Study: 21952034

Group type: EXPERIMENTAL
Intervention: 1 mg vitamin B12 pill taken daily and routine PACAM food
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Placebo pill and milk-PACAM food fortified to provide 1 mg of vitamin B12
Number of subjects: 300

Group type: COMPARATOR
Intervention: Routine PACAM food and placebo pill
Number of subjects: 300
Study: 18978634

Group type: EXPERIMENTAL
Intervention: Antidepressant medication management plus relapse prevention cognitive-behavioral therapy (MM+CBT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Antidepressant medication management (MM)
Number of subjects: 46
Study: 17013852

Group type: EXPERIMENTAL
Intervention: 6-week exercise intervention
Number of subjects: 108

Group type: COMPARATOR
Intervention: Education (control)
Number of subjects: 108
Study: 12729423

Group type: EXPERIMENTAL
Intervention: 10-day oral doxycycline
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 20-day oral doxycycline
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Doxycycline + ceftriaxone (single intravenous dose)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group without Lyme disease
Number of subjects: 180
Study: 10934099

Group type: EXPERIMENTAL
Intervention: Inhaled PGE(2) (100 microgram)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8959182

Group type: EXPERIMENTAL
Intervention: Ionic contrast material (ioxaglate)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Nonionic contrast material (iopamidol or iohexol)
Number of subjects: 98
Study: 1525104

Group type: EXPERIMENTAL
Intervention: gemeprost alone (1 mg every 6 h up to three doses)
Number of subjects: 301

Group type: COMPARATOR
Intervention: mifepristone (200‐600 mg) followed 48 h later by a single dose of gemeprost (1 mg)
Number of subjects: 301

Group type: COMPARATOR
Intervention: mifepristone and gemeprost
Number of subjects: 301
Study: 3761089

Group type: EXPERIMENTAL
Intervention: Mother's own milk (HM) with protein intake 3.3 gm/kg day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Fortified mother's own milk (fortified HM) with protein intake 4.5 gm/kg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Similac Special Care (Similac SC) with protein intake 2.9 gm/kg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Similac with protein intake 2.7 gm/kg/day
Number of subjects: 38
Study: 28982101

Group type: EXPERIMENTAL
Intervention: Misoprostol (2 tablets, 400 µg administered vaginally 12 hours before hysteroscopy)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (2 placebo tablets administered)
Number of subjects: 100
Study: 27176138

Group type: EXPERIMENTAL
Intervention: Rolapitant (180 mg)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study: 24112749

Group type: EXPERIMENTAL
Intervention: Self-measurement of INR using a personal device
Number of subjects: 178

Group type: COMPARATOR
Intervention: Laboratory-analyzed INR monitoring
Number of subjects: 178
Study: 22351940

Group type: EXPERIMENTAL
Intervention: ASP2151 (100 mg daily for 3 days)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: ASP2151 (200 mg daily for 3 days)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: ASP2151 (400 mg daily for 3 days)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: ASP2151 (1200 mg as a single dose)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Valacyclovir (500 mg twice daily for 3 days)
Number of subjects: 437

Group type: COMPARATOR
Intervention: Placebo for 3 days
Number of subjects: 437
Study: 21211387

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA) under deep anesthesia (group LM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intratracheal tube extubation when awake (group TT)
Number of subjects: 40
Study: 18692661

Group type: EXPERIMENTAL
Intervention: Right gastroepiploic artery graft
Number of subjects: 370

Group type: COMPARATOR
Intervention: Saphenous vein graft
Number of subjects: 370
Study: 15907554

Group type: EXPERIMENTAL
Intervention: Caspofungin (50 mg/day after a 70 mg loading dose)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Amphotericin B (0.6-1.0 mg/kg/day)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Caspofungin
Number of subjects: 224

Group type: COMPARATOR
Intervention: Amphotericin B
Number of subjects: 224
Study: 14753637

Group type: EXPERIMENTAL
Intervention: Midazolam (mean 12.5 mg)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Diazepam (mean 28.1 mg)
Number of subjects: 141
Study: 10496496

Group type: EXPERIMENTAL
Intervention: NISWT
Number of subjects: 24
Study: 8541435

Group type: EXPERIMENTAL
Intervention: Balanced anaesthesia technique with isoflurane and fentanyl
Number of subjects: 15

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia with propofol and alfentanil
Number of subjects: 15
Study: 1752112

Group type: EXPERIMENTAL
Intervention: Pefloxacin alone (period A)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pefloxacin after a 10-day induction by rifampin (period B)
Number of subjects: 8
Study: 7457638

Group type: EXPERIMENTAL
Intervention: 3 mg/kg of caffeine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 10 mg/kg of caffeine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31200757

Group type: EXPERIMENTAL
Intervention: Bridge intervention to identify, test, and link HIV-positive PWID to HIV care
Number of subjects: 24

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 24
Study: 27787672

Group type: EXPERIMENTAL
Intervention: Reinforcement
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.3 and 0.6 mg/kg)
Number of subjects: 29
Study: 25906785

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Trimester 1 mean glucose
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Trimester 2 mean glucose
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Trimester 3 mean glucose
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Glucose levels at specific times of day
Number of subjects: 117
Study: 24412457

Group type: EXPERIMENTAL
Intervention: Drug-eluting balloon (DEB)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Combined clinical outcome measure (cardiac death, myocardial infarction, target vessel revascularization)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Target vessel revascularization
Number of subjects: 189
Study: 22982353

Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring (CVR) delivering 150/15 μg Nestorone®/ethinyl estradiol (EE) daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Oral contraceptive (OC) containing levonorgestrel and EE (150/30 μg)
Number of subjects: 45
Study: 19383221

Group type: EXPERIMENTAL
Intervention: Valsartan/hydrochlorothiazide 80 mg/12.5 mg once daily
Number of subjects: 65

Group type: COMPARATOR
Intervention: Amlodipine 5 mg once daily
Number of subjects: 65
Study: 17461960

Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chlorhexidine (CHX)
Number of subjects: 30
Study: 15113295

Group type: EXPERIMENTAL
Intervention: Cotton wool with petroleum jelly
Number of subjects: 10

Group type: COMPARATOR
Intervention: Other earplugs
Number of subjects: 10
Study: 12270068

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No therapy or placebo
Number of subjects: 19
Study: 9717596

Group type: EXPERIMENTAL
Intervention: 4 ml lidocaine 1%
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 6 ml lidocaine 1%
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 8 ml lidocaine 1%
Number of subjects: 48
Study: 8122656

Group type: EXPERIMENTAL
Intervention: Ketoconazole 200 mg/day p.o.
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Fluconazole 50 mg/day p.o.
Number of subjects: 122

Group type: COMPARATOR
Intervention: No antifungal therapy
Number of subjects: 122
Study: 2549204

Group type: EXPERIMENTAL
Intervention: 500 mg/m2 as a continuous intravenous (IV) infusion over 24 hours
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Five consecutive daily 2-hour infusions each of 100 mg/m2
Number of subjects: 39
Study: 16815

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31422486

Group type: EXPERIMENTAL
Intervention: Fast Food (FF) diet
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mediterranean (Med) diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 10
Study: 28870034

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 560
Study: 26160368

Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention (Tele-HF trial)
Number of subjects: 1427
Study: 23204058

Group type: EXPERIMENTAL
Intervention: Early tracheostomy (within day 1-3 from intubation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard tracheostomy (between day 7-14 from intubation)
Number of subjects: 60
Study: 21865202

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (C and E)
Number of subjects: 567
Study: 18926516

Group type: EXPERIMENTAL
Intervention: Drain placed (group A)
Number of subjects: 284

Group type: COMPARATOR
Intervention: No drain placed (group B)
Number of subjects: 284
Study: 16960528

Group type: EXPERIMENTAL
Intervention: Esophageal acid perfusion (0.1 N HCl perfused)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acid perfusion during exercise
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rabeprazole (RAB) 20 mg x d(‐1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham esophageal infusion (NG tube placed in the distal esophagus, no fluid)
Number of subjects: 24
Study: 15240411

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tianeptine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroop test performance
Number of subjects: 0
Study: 10676793

Group type: EXPERIMENTAL
Intervention: Uncorrected refractive error
Number of subjects: 5147

Group type: EXPERIMENTAL
Intervention: Diabetic retinopathy
Number of subjects: 5147

Group type: EXPERIMENTAL
Intervention: Glaucoma
Number of subjects: 5147

Group type: EXPERIMENTAL
Intervention: Cataract
Number of subjects: 5147

Group type: EXPERIMENTAL
Intervention: Age-related macular degeneration
Number of subjects: 5147
Study: 9678107

Group type: EXPERIMENTAL
Intervention: Monophasic COC containing 30 micrograms ethinylestradiol and 75 micrograms gestodene
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Triphasic COC containing 30/40/30 ethinylestradiol and 50/70/100 micrograms gestodene
Number of subjects: 44
Study: 8471132

Group type: EXPERIMENTAL
Intervention: Debrisoquin (DBQ), an inhibitor of monoamine oxidase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 3520794

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg daily
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cimetidine 1600 mg daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cimetidine 400 mg single-dose maintenance treatment
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 29503145

Group type: EXPERIMENTAL
Intervention: Supplementation with fish oil (1.7 g EPA + DHA/day), chocolate containing plant sterols (2.2 g/day), and green tea (two sachets/day) for 6 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Statin dose reduction by 50% from weeks 6-12 after 6 weeks of standard therapy
Number of subjects: 53
Study: 26416996

Group type: EXPERIMENTAL
Intervention: Intensive follow-up
Number of subjects: 964

Group type: COMPARATOR
Intervention: Usual follow-up (Control)
Number of subjects: 964
Study: 25352050

Group type: EXPERIMENTAL
Intervention: Tuina massage therapy (20 minutes, 4-step treatment protocol, 20 sessions over 4 weeks)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional analgesics (specific daily dose of ibuprofen)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tuina massage therapy
Number of subjects: 150
Study: 22343553

Group type: EXPERIMENTAL
Intervention: Physiological sex steroid replacement (pSSR)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard sex steroid replacement (sSSR)
Number of subjects: 34
Study: 20199783

Group type: EXPERIMENTAL
Intervention: External limb compression at 100 mm Hg (EC100)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External limb compression at 160 mm Hg (EC160)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-intensity resistance exercise (no external compression)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-intensity resistance exercise (70% of 1-repetition maximum)
Number of subjects: 0
Study: 19087716

Group type: EXPERIMENTAL
Intervention: EEN + glutamine and arginine (enteral immunonutrition group), n = 14
Number of subjects: 32

Group type: COMPARATOR
Intervention: EEN group, n = 18
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups (EEN and enteral immunonutrition)
Number of subjects: 32
Study: 17112304

Group type: EXPERIMENTAL
Intervention: Rimonabant 20mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12966301

Group type: EXPERIMENTAL
Intervention: Unipolar hemiarthroplasty
Number of subjects: 115

Group type: COMPARATOR
Intervention: Bipolar hemiarthroplasty
Number of subjects: 115
Study: 10785528

Group type: EXPERIMENTAL
Intervention: Educational intervention for nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 0
Study: 8862940

Group type: COMPARATOR
Intervention: Chlorthalidone 50 mg
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 50 mg/triamterene 50 mg combination treatment
Number of subjects: 141
Study: 1736500

Group type: EXPERIMENTAL
Intervention: Low-dose diethylstilbestrol (DES) 1 mg daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 6225627

Group type: EXPERIMENTAL
Intervention: 5 percent benzoyl peroxide acetone gel for four weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 percent benzoyl peroxide acetone gel for an additional four weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (acetone gel vehicle)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide acetone gel
Number of subjects: 0
Study: 30131297

Group type: EXPERIMENTAL
Intervention: Inhaled vancomycin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 29
Study: 29712666

Group type: EXPERIMENTAL
Intervention: Oral vitamin D3 (100,000 IU or 12,000 IU, n = 31 each) administered once monthly for 2 years
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Oral vitamin D3 (standard dose 12,000 IU) administered once monthly for 2 years
Number of subjects: 62
Study: 27271717

Group type: EXPERIMENTAL
Intervention: Local cement reinforcing antibacterial implant
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study: 25212457

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral training program for children with FAP (n = 56)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Active control group focusing on age-appropriate information delivery (n = 56)
Number of subjects: 112
Study: 22287058

Group type: EXPERIMENTAL
Intervention: V‐Loc™ 180 Wound Closure Device
Number of subjects: 2

Group type: COMPARATOR
Intervention: Quill™ PDO Knotless Tissue‐Closure Device
Number of subjects: 2
Study: 21504972

Group type: EXPERIMENTAL
Intervention: Fermented dairy product containing Lactobacillus casei DN-114 001 (verum)
Number of subjects: 1000
Study: 17398307

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 20 mg intravenously, started 12 hours before extubation and every 4 hours until tube removal
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 20 mg intravenously
Number of subjects: 698

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 698
Study: 16142596

Group type: EXPERIMENTAL
Intervention: Captopril 12.5 mg administered at night
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo administered at night
Number of subjects: 121
Study: 12142389

Group type: EXPERIMENTAL
Intervention: Megestrol acetate
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitor (fadrozole)
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Increased serum HER-2/neu
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Increased serum CA 15-3
Number of subjects: 566
Study: 9925695

Group type: EXPERIMENTAL
Intervention: Disposable forceps
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Alligator-shaped forceps
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Absence of a needle within the cup
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Oval-shaped forceps
Number of subjects: 55

Group type: COMPARATOR
Intervention: Individual biopsy forceps
Number of subjects: 55
Study: 7738458

Group type: COMPARATOR
Intervention: Standard double-blind study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental treatment
Number of subjects: 0